What are the differences between younger and older patients with symptomatic small vessel disease?

Aleksandra M Pavlović1, Tatjana Pekmezović, Jasna Zidverc-Trajković

  • 1Clinic for Neurology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. aleksandrapavlovic@hotmail.com

Abstract

Insights

Small vessel disease (SVD) affects younger adults, with smoking as a key risk factor. While younger patients show better function and cognition, many still experience deficits, highlighting the need for early intervention.

Area of Science:

  • Neurology
  • Vascular Neurology
  • Neuroimaging

Background:

  • Small vessel disease (SVD) is typically associated with aging.
  • However, SVD can occur in younger adults, often linked to vascular risk factors.
  • Understanding early-onset SVD is crucial for timely diagnosis and management.

Purpose of the Study:

  • To investigate the characteristics of small vessel disease (SVD) in early adult patients.
  • To compare features of SVD between younger (35-55 years) and older (>56 years) patient groups.

Main Methods:

  • Analysis of 200 consecutive patients with cerebral SVD.
  • Assessment of vascular risk factors, functional and cognitive status.
  • Evaluation of SVD severity using the Age-Related White Matter Changes (ARWMC) scale on MRI.

Main Results:

  • Smoking was an independent predictor of SVD in younger patients (OR 2.9).
  • Younger patients exhibited better functional and cognitive status but still had deficits in two-thirds.
  • Lower ARWMC scores were observed in younger patients, correlating with better functional and cognitive outcomes.

Conclusions:

  • Younger SVD patients share vascular risk factors with older counterparts.
  • Early-onset SVD is associated with better functional and cognitive status and less severe MRI changes.
  • Despite better outcomes, a significant proportion of younger SVD patients experience deficits, underscoring the importance of early detection.

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...